Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 study assessing pharmacokinetics, safety, and effectiveness of certolizumab pegol in children with moderate to severe chronic plaque psoriasis has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis in Children

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED